Biofrontera

Biofrontera cleared of wrongdoing in Nasdaq IPO
Fierce Biotech
Thu, 12/13/18 - 10:10 pm
Biofrontera
IPOs
NASDAQ
Biofrontera files for IPO to run skin cancer clinical trials
Fierce Biotech
Mon, 01/15/18 - 10:36 am
Biofrontera
IPO
clinical trials
skin cancer
FDA approves Biofrontera’s drug-device combo for sun-induced skin cancer
Mass Device
Fri, 05/13/16 - 10:36 am
FDA
Biofrontera
devices
skin cancer
Ameluz
BF-RhodoLED